VANCOUVER, Aug. 6 /CNW/ - Burcon NutraScience Corporation (TSX -BU) ("Burcon" or the "Corporation") announced today that it has engaged Mr. Sven Olsson of Goeppingen, Germany, to perform investor relations services by assisting Burcon with communicating its corporate message to financial markets in Europe. Mr. Olsson has been working on behalf of Burcon over the last six years when he was with AXINO AG, a Stuttgart based investor relations firm. Burcon will continue to use the services of AXINO AG for its general investor relations activities in Europe.
Mr. Olsson is an accomplished professional with over fifteen years in the communications business of which he dedicated the last eight years to the North American investment and finance industry. Since 2001, Mr. Olsson has held the position of Director of Media and Corporate Communications at AXINO AG, a European consulting firm specializing in communications for companies in the resource sector. In his role, Mr. Olsson was responsible for investor relations in Europe for numerous major and micro cap resource-based companies in all phases of development. His network of contacts within the financial communities as well as media extends across Europe and North America.
The Investor Relations Service Agreement (the "Agreement") has a term of 24 months. The Agreement is also terminable upon 30 days notice by either party. The Corporation will pay Mr. Olsson (euro)750 per day for attendance at investor meetings in Europe and has also granted him an option to purchase up to a total of 15,000 Common shares in the capital of Burcon at an exercise price of $6.10 per share. The option will have a term of five years from the date of grant and will vest as to 33 1/3% on the date that is 8, 16 and 24 months from the date of grant, respectively.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing the world's first commercial canola proteins, Puratein(R) and Supertein(TM) with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 86 issued patents in various countries, including 8 issued U.S. patents, and in excess of 200 additional pending patent applications, 61 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS "Johann F. Tergesen" Johann F. Tergesen President and Chief Operating Officer
Burcon NutraScience Corporation is a publicly listed on the Toronto Stock Exchange under the symbol "BU". For more information on Burcon, visit www.burcon.ca.
This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, the Corporation's, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal", "intend", "believes", "potential", "expected", "anticipates", "will be", and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.